We have located links that may give you full text access.
A genome-wide association study identifying RAP1A as a novel susceptibility gene for Crohn's disease in Japanese individuals.
Journal of Crohn's & Colitis 2018 November 30
Background and Aims: Genome-wide association studies (GWASs) of European populations have identified numerous susceptibility loci for Crohn's disease (CD). Susceptibility genes differ by ethnicity, however, so GWASs specific for Asian populations are required. This study aimed to clarify the Japanese-specific genetic background for CD by a GWAS using the Japonica array (JPA) and subsequent imputation with the 1KJPN reference panel.
Methods: Two independent Japanese case/control sets (Tohoku region [379 CD patients, 1621 controls] and Kyushu region [334 CD patients, 462 controls]) were included. GWASs were performed separately for each population followed by a meta-analysis. Two additional replication sets (254 + 516 CD patients and 287 + 565 controls) were analysed for top hit SNPs from novel genomic regions.
Results: Genotype data of 4,335,144 SNPs from 713 Japanese CD patients and 2083 controls were analysed. SNPs located in TNFSF15 (rs78898421, Pmeta = 2.59 × 10-26, odds ratio [OR] = 2.10), HLA-DQB1 (rs184950714, Pmeta = 3.56 × 10-19, OR = 2.05), ZNF365 and 4p14 loci were significantly associated with CD in Japanese individuals. Replication analyses were performed for four novel candidate loci (P < 1 × 10-6), and rs488200 located upstream of RAP1A was significantly associated with CD (Pcombined = 4.36 × 10-8, OR = 1.31). Transcriptome analysis of CD4+ effector memory T cells from lamina propria mononuclear cells of CD patients revealed a significant association of rs488200 with RAP1A expression.
Conclusion: RAP1A is a novel susceptibility locus for CD in the Japanese population.
Methods: Two independent Japanese case/control sets (Tohoku region [379 CD patients, 1621 controls] and Kyushu region [334 CD patients, 462 controls]) were included. GWASs were performed separately for each population followed by a meta-analysis. Two additional replication sets (254 + 516 CD patients and 287 + 565 controls) were analysed for top hit SNPs from novel genomic regions.
Results: Genotype data of 4,335,144 SNPs from 713 Japanese CD patients and 2083 controls were analysed. SNPs located in TNFSF15 (rs78898421, Pmeta = 2.59 × 10-26, odds ratio [OR] = 2.10), HLA-DQB1 (rs184950714, Pmeta = 3.56 × 10-19, OR = 2.05), ZNF365 and 4p14 loci were significantly associated with CD in Japanese individuals. Replication analyses were performed for four novel candidate loci (P < 1 × 10-6), and rs488200 located upstream of RAP1A was significantly associated with CD (Pcombined = 4.36 × 10-8, OR = 1.31). Transcriptome analysis of CD4+ effector memory T cells from lamina propria mononuclear cells of CD patients revealed a significant association of rs488200 with RAP1A expression.
Conclusion: RAP1A is a novel susceptibility locus for CD in the Japanese population.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app